Immunological applications of stem cells in type 1 diabetes

Endocrine Reviews

Volumn 32, Issue 6, 2011, Pages 725-754

  Fiorina, Paolo ^a,b   Voltarelli, Julio ^c   Zavazava, Nicholas ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CYTOKINE; ENDOGLIN; GLUCOSE; INSULIN; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; KRUPPEL LIKE FACTOR 4; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL ISOLATION; CELL MATURATION; CELL MIGRATION; CELL PROTECTION; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; CULTURE TECHNIQUE; EMBRYONIC STEM CELL; EPIGENETICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; INSULITIS; LIVER REGENERATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSULIN-SECRETING CELLS; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 83755195365     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-0008     Document Type: Review

References (264)

1. Colucci F, Cilio CM 2010 Taming killer cells may halt diabetes progression. Nat Immunol 11:111-112
2. Karges B, Kapellen T, Neu A, Hofer SE, Rohrer T, Rosenbauer J, Wolf J, Holl RW 2010 Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Diabetes Care 33:1031-1033
3. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
4. Patterson CC, Dahlquist GG, Gyürüs E, Green A, SoltészG 2009 Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373: 2027-2033
5. 2000 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med [Erratum (2000) 342:1376] 342: 381-389
6. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M 1998 Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75
7. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS 1990 Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322:1031-1037
8. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A 2001 Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 50:496-501
9. Couri CE, Voltarelli JC 2009 Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetol Metab Syndr 1:19
10. Bluestone JA, Herold K, Eisenbarth G 2010 Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300
11. Nir T, Melton DA, Dor Y 2007 Recovery from diabetes in mice by cell regeneration. J Clin Invest 117:2553-2561
12. Zaret KS, Grompe M 2008 Generation and regeneration of cells of the liver and pancreas. Science 322:1490-1494
13. Aguayo-Mazzucato C, Bonner-Weir S 2010 Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 6:139-148
14. Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R 2009 Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183:993-1004
15. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM 1998 Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147
16. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD,MoormanMA,SimonettiDW,Craig S, Marshak DR 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
17. Anderson DJ, Gage FH, Weissman IL 2001 Can stem cells cross lineage boundaries? Nat Med 7:393-395
18. Williams DA 2009 National Institutes of Health releases new guidelines on human stem cell research. Mol Ther 17:1485-1486
19. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH 2008 Immunomodulation by mesenchymal stem cells. Diabetes 57:1759-1767
20. Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, Guiducci S, Jones S, Jorgensen C, Le Blanc K, Luyten F, McGonagle D, Martin I, Bocelli-Tyndall C, Pennesi G, Pistoia V, Pitzalis C, Uccelli A, Wulffraat N, FeldmannM 2007 Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9:301
21. Francese R, Fiorina P 2010 Immunological and regenerative properties of cord blood stem cells. Clin Immunol 136: 309-322
22. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G 2009 Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. JAmSoc Nephrol 20:1053-1067
23. Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, ZernMA,Fleischer N, Efrat S 2003 Reversal of hyperglycemia in mice by using human expandable insulinproducing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci USA 100:7253-7258
24. Friel R, van der Sar S, Mee PJ 2005 Embryonic stem cells: understanding their history, cell biology and signalling. Adv Drug Deliv Rev 57:1894-1903
25. Bonde S, Zavazava N 2006 Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192-2201
26. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, GuentherMG,Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA 2005 Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956
27. Mayshar Y, Rom E, Chumakov I, Kronman A, Yayon A, Benvenisty N 2008 Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells 26: 767-774
28. Hall J, Guo G, Wray J, Eyres I, Nichols J, Grotewold L, Morfopoulou S, Humphreys P, Mansfield W, Walker R, Tomlinson S, Smith A 2009 Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell selfrenewal. Cell Stem Cell 5:597-609
29. Davey RE, Onishi K, Mahdavi A, Zandstra PW 2007 LIFmediated control of embryonic stem cell self-renewal emerges due to an autoregulatory loop. FASEB J 21:2020-2032
30. Katoh M 2011 Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol 12:160-170
31. Ginis I, Luo Y, Miura T, Thies S, Brandenberger R, Gerecht-Nir S, Amit M, Hoke A, Carpenter MK, Itskovitz-Eldor J, Rao MS 2004 Differences between human and mouse embryonic stem cells. Dev Biol 269:360-380
32. Hoffman LM, Carpenter MK 2005 Characterization and culture of human embryonic stem cells. Nat Biotechnol 23:699-708
33. Koestenbauer S, Zech NH, Juch H, Vanderzwalmen P, Schoonjans L, Dohr G 2006 Embryonic stem cells: similarities and differences between human and murine embryonic stem cells. Am J Reprod Immunol 55:169-180
34. Ström S, Inzunza J, Grinnemo KH, Holmberg K, Matilainen E, Strö mberg AM, Blennow E, Hovatta O 2007 Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum Reprod 22:3051-3058
35. Suss-Toby E, Gerecht-Nir S, Amit M, Manor D, Itskovitz-Eldor J 2004 Derivation of a diploid human embryonic stem cell line from a mononuclear zygote. Hum Reprod 19:670-675
36. Conley BJ, Young JC, Trounson AO, Mollard R 2004 Derivation, propagation and differentiation of human embryonic stem cells. Int J Biochem Cell Biol 36:555-567
37. Bonde S, Chan KM, Zavazava N 2008 ES-Cell derived hematopoietic cells induce transplantation tolerance. PLoS ONE 3:e3212
38. Boyd AS, Higashi Y, Wood KJ 2005 Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev 57:1944-1969
39. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221-229
40. Boyd AS, Wood KJ 2010 Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One 5:e10965
41. Kofidis T, deBruin JL, Tanaka M, Zwierzchoniewska M, Weissman I, Fedoseyeva E, Haverich A, Robbins RC 2005 They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardiothorac Surg 28:461-466
42. Fändrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, Holle J, Huang DS, Parwaresch R, Zavazava N, Binas B 2002 Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171-178
43. Baertschiger RM, Gonelle-Gispert C, Morel P, Sgroi A, Serre-Beinier V, Stouffs M, Jaconi ME, Bühler LH 2010 Transplantation of mouse embryonic stem cells induces hematopoietic and tissue chimerism in rats. Xenotransplantation 17:362-369
44. Lee JE, Kang MS, Park MH, Shim SH, Yoon TK, Chung HM, Lee DR 2010 Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes. Cell Transplant 19:1383-1395
45. Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE 2005 SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 23: 1324-1332
46. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, Kay TW 2004 IL-1 receptor deficiency slows progression to diabetes in theNODmouse. Diabetes 53:113-121
47. Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R 2010 Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes 59: 3139-3147
48. Wang R, Han G, Wang J, Chen G, Xu R, Wang L, Li X, Shen B, Li Y 2008 The pathogenic role of interleukin-27 in autoimmune diabetes. Cell Mol Life Sci 65:3851-3860
49. Leng Q, Nie Y, Zou Y, Chen J 2008 Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development. BMC Immunol 9:51
50. Soria B, Roche E, Berná G, León-Quinto T, Reig JA, Martín F 2000 Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157-162
51. Humphrey RK, Bucay N, Beattie GM, Lopez A, Messam CA, Cirulli V, Hayek A 2003 Characterization and isolation of promoter-defined nestin-positive cells from the human fetal pancreas. Diabetes 52:2519-2525
52. Lee JH, Lee EJ, Lee CH, Park JH, Han JY, Lim JM 2009 Requirement of leukemia inhibitory factor for establishing and maintaining embryonic stem cells in mice. Fertil Steril 92:1133-1140
53. Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus AM 2003 Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 100: 998-1003
54. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK, Baetge EE 2008 Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443-452
55. D'AmourKA,BangAG,Eliazer S, KellyOG,AgulnickAD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE 2006 Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24:1392-1401
56. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, Mc-Kay R 2001 Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394
57. Naujok O, Francini F, Picton S, Jö rns A, Bailey CJ, Lenzen S 2008 A new experimental protocol for preferential differentiation of mouse embryonic stem cells into insulinproducing cells. Cell Transplant 17:1231-1242
58. Naujok O, Francini F, Picton S, Bailey CJ, Lenzen S, Jörns A 2009 Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin-producing cells in vitro and in vivo. Diabetes Metab Res Rev 25:464-476
59. Li G,LuoR,ZhangJ,YeoKS, LianQ,Xie F,TanEK, Caille D, Kon OL, Salto-Tellez M, Meda P, Lim SK 2009 Generating mESC-derived insulin-producing cell lines through an intermediate lineage-restricted progenitor line. Stem Cell Res 2:41-55
60. Zhang D, Jiang W, Shi Y, Deng H 2009 Generation of pancreatic islet cells from human embryonic stem cells. Sci China C Life Sci 52:615-621
61. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H 2009 Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 19:429-438
62. Li H, Lam A, Xu AM, Lam KS, Chung SK 2010 High dosage of Exendin-4 increased early insulin secretion in differentiated cells from mouse embryonic stem cells. Acta Pharmacol Sin 31:570-577
63. Lee SH, Hao E, Savinov AY, Geron I, Strongin AY, Itkin-Ansari P 2009 Human b-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 87: 983-991
64. Shao S, Gao Y, Xie B, Xie F, Lim SK, Li G 2011 Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor. J Endocrinol 208:245-255
65. XuYN,Guan N,WangZD, Shan ZY, Shen JL, ZhangQH, Jin LH, Lei L 2009 ES cell extract-induced expression of pluripotent factors in somatic cells. Anat Rec (Hoboken) 292:1229-1234
66. Burt RK, Verda L, Kim DA, Oyama Y, Luo K, Link C 2004 Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 199:895-904
67. Mohib K, Allan D, Wang L 2010 Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells. Stem Cell Rev 6:611-621
68. Rajasingh J, Lambers E, Hamada H, Bord E, Thorne T, Goukassian I, Krishnamurthy P, Rosen KM, Ahluwalia D, Zhu Y, Qin G, Losordo DW, Kishore R 2008 Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res 102:e107-e117
69. Rippon HJ, Lane S, Qin M, Ismail NS, WilsonMR, Takata M, Bishop AE 2008 Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. ProcAmThorac Soc 5:717-722
70. Blum B, Benvenisty N 2009 The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822-3830
71. Knoepfler PS 2009 Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27:1050-1056
72. Kooreman NG, Wu JC 2010 Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface 7(Suppl 6):S753-S763
73. Oh W, Kim DS, Yang YS, Lee JK 2008 Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 251:116-123
74. Verneris MR, Miller JS 2009 The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Br J Haematol 147:185-191
75. McGuckin CP, Forraz N 2008 Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif 41:31-40
76. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA 2009 Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11:377-391
77. La Motte-Mohs RN, Herer E, Zúñiga-Pflücker JC 2005 Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105:1431-1439
78. Parekh VS, Joglekar MV, Hardikar AA 2009 Differentiation of human umbilical cord blood-derived mononuclear cells to endocrine pancreatic lineage. Differentiation 78: 232-240
79. Huang CJ, Butler AE, Moran A, Rao PN, Wagner JE, Blazar BR, Rizza RA, Manivel JC, Butler PC 2011 A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans. Diabetologia 54:1066-1074
80. Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, Abella EM, Harrison DD, Zanjani ED 1996 Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335:1806-1810
81. Rogers I, Casper RF 2004 Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 18:893-908
82. Lazzari L, Lucchi S, Montemurro T, Porretti L, Lopa R, Rebulla P, Sirchia G 2001 Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood. Bone Marrow Transplant 28: 693-698
83. Domanska-Janik K, Buzanska L, Lukomska B 2008 A novel, neural potential of non-hematopoietic human umbilical cord blood stem cells. Int J Dev Biol 52:237-248
84. Kita K, Gauglitz GG, Phan TT, Herndon DN, JeschkeMG 2010 Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19:491-502
85. Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D 2010 Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 45:219-234
86. Zuba-Surma EK, Ratajczak MZ 2010 Overview of very small embryonic-like stem cells (VSELs) and methodology of their identification and isolation by flow cytometric methods. Curr Protoc Cytom Unit 9.29
87. Zuba-Surma EK, Wu W, Ratajczak J, Kucia M, Ratajczak MZ 2009 Very small embryonic-like stem cells in adult tissues-potential implications for aging. Mech Ageing Dev 130:58-66
88. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, Czajka R, Wojakowski W, Machalinski B, Ratajczak MZ 2007 Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified fromhumancord blood-preliminary report. Leukemia 21:297-303
89. Martins AA, Paiva A, Morgado JM, Gomes A, Pais ML 2009 Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc 41:943-946
90. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, Broun ER 1992 Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109-4113
91. Broxmeyer HE 2010 Cord blood hematopoietic stem cell transplantation. StemBook. Boston: Harvard Stem Cell Institute, Harvard University
92. Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, Xu J 2009 The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:220-232
93. Zhao Y, Lin B, Darflinger R, Zhang Y, Holterman MJ, Skidgel RA 2009 Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS ONE 4:e4226
94. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, Harris IR, Popma SH, Sachs DH, Huang CA 2008 Immunogenicity of umbilical cord tissue derived cells. Blood 111:430-438
95. Wang D, Chen K, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Bayard F, Zhu D, Han ZC 2010 CD14+ monocytes promote the immunosuppressive effect ofhumanumbilical cord matrix stem cells. Exp Cell Res 316:2414-2423
96. Li L, Godfrey WR, Porter SB, Ge Y, June CH, Blazar BR, Boussiotis VA 2005 CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106:3068-3073
97. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, June CH, Blazar BR, Porter SB 2005 Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105:750-758
98. Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, SuhoskiMM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR 2008 Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigenpresenting cells. Blood 112:2847-2857
99. Newman MB, Willing AE, Manresa JJ, Sanberg CD, Sanberg PR 2006 Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol 199:201-208
100. Liu Y, Liu T, Ma X, Fan X, Bao C, Cui Z 2009 Effects of encapsulated rabbit mesenchymal stem cells on ex vivo expansion of human umbilical cord blood hematopoietic stem/progenitor cells. J Microencapsul 26:130-142
101. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A 2006 Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromalderived factor-1-CXCR4 and hepatocyte growth factor-cmet axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264
102. Castellani ML, Perrella A, Kempuraj DJ, Boucher W, Tagen M, Salini V, Vecchiet J, Tetè S, Frydas S, Theoharides TC, Conti P 2007 Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expression. Pharmacol Res 55:57-63
103. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR 2005 Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev 14:576-586
104. Kim YJ, Broxmeyer HE 2011 Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 79:112-126
105. Penolazzi L, Lambertini E, Tavanti E, Torreggiani E, Vesce F, Gambari R, Piva R 2008 Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology. Cell Biol Int 32:320-325
106. Pessina A, Eletti B, Croera C, Savalli N, Diodovich C, Gribaldo L 2004 Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun 323:315-322
107. Yoshida S, Ishikawa F, Kawano N, Shimoda K, Nagafuchi S, Shimoda S, Yasukawa M, Kanemaru T, Ishibashi H, Shultz LD, Harada M 2005 Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells 23:1409-1416
108. Denner L, Bodenburg Y, Zhao JG, Howe M, Cappo J, Tilton RG, Copland JA, Forraz N, McGuckin C, Urban R 2007 Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif 40:367-380
109. Sun B, Roh KH, Lee SR, Lee YS, Kang KS 2007 Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing isletlike structure. Biochem Biophys Res Commun 354:919-923
110. Gao F, Wu DQ, Hu YH, Jin GX, Li GD, Sun TW, Li FJ 2008 In vitro cultivation of islet-like cell clusters from humanumbilical cord blood-derived mesenchymal stem cells. Transl Res 151:293-302
111. Hu YH, Wu DQ, Gao F, Li GD, Zhang XC 2010 Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. ChinMedJ (Engl) 123:606-614
112. Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA 2009 Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 32:2041-2046
113. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K 2006 Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301
114. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C 2004 Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384
115. Pittenger MF, Martin BJ 2004 Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20
116. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ 2004 Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668
117. MiuraM,Miura Y, Padilla-NashHM,Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S 2006 Accumulated chromosomal instability in murine bonemarrowmesenchymal stem cells leads to malignant transformation. Stem Cells 24:1095-1103
118. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR 2007 Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25:371-379
119. Li H, Fan X, Kovi RC, Jo Y, Moquin B, Konz R, Stoicov C, Kurt-Jones E, Grossman SR, Lyle S, Rogers AB, Montrose M, Houghton J 2007 Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 67:10889-10898
120. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrødder H, Jensen T, Kassem M 2004 Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095-5098
121. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O 2007 Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11:421-429
122. Li N, Yang R, Zhang W, Dorfman H, Rao P, Gorlick R 2009 Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer 115:4795-4806
123. Wu C, Nik-Amini S, Nadesan P, Stanford WL, Alman BA 2010 Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells. Cancer Res 70:7690-7698
124. Saldanha-Araujo F, Haddad R, Zanette DL, De Araujo AG, Orellana MD, Covas DT, Zago MA, Panepucci RA 2010 Cancer/testis antigen expression on mesenchymal stem cells isolated from different tissues. Anticancer Res 30:5023-5027
125. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ 2010 Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124:317-326
126. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA 2010 Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 5:e12180
127. Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, Bosco R, Ingrao S, Zavan B, Zauli G 2010 Human bone marrow mesenchymal stem cells display anticancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One 5:e11140
128. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P 2010 Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-b. J Immunol 184:5885-5894
129. Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, Clise-Dwyer K, Wang RY, Zhang W, Yuan X, Lu H, Caldwell L, Andreeff M 2010 Mesenchymal stem cells overexpressing IFN-b inhibit breast cancer growth and metastases through Stat3 signaling in a syngeneic tumor model. Cancer Microenviron 3:83-95
130. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX 2010 Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 101:2546-2553
131. Caterson EJ, Nesti LJ, Danielson KG, Tuan RS 2002 Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 20:245-256
132. Gnecchi M, Melo LG 2009 Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 482:281-294
133. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM 2001 Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402
134. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D 2008 Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng PartCMethods 14:185-196
135. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J 2005 Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106:4057-4065
136. Chen L, Tredget EE, Liu C, Wu Y 2009 Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One 4:e7119
137. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM 2009 Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 30:2722-2732
138. HuangXP, Sun Z, Miyagi Y,McDonaldKinkaid H, Zhang L, Weisel RD, Li RK 2010 Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122:2419-2429
139. El Haddad N, Heathcote D, Moore R, Yang S, Azzi J, Mfarrej B, Atkinson M, Sayegh MH, Lee JS, Ashton-Rickardt PG, Abdi R 2011 Mesenchymal stem cells express serine protease inhibitor to evade host immune response. Blood 117:1176-1183
140. Sundin M, Barrett AJ, Ringdén O, Uzunel M, Lö nnies H, Dackland AL, Christensson B, Blanc KL 2009 HSCT recipients have specific tolerance toMSCbut not to theMSC donor. J Immunother 32:755-764
141. Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G 2005 Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35:1482-1490
142. Meisel R, Zibert A, Laryea M, Gö bel U, Däubener W, Dilloo D 2004 Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621
143. Benvenuto F, Ferrari S, Gerdoni E, Gualandi F, Frassoni F, Pistoia V, Mancardi G, Uccelli A 2007 Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25:1753-1760
144. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE 2006 Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080-2087
145. Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, Le AD 2009 Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183:7787-7798
146. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N 2005 Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126
147. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L 2009 MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576-6583
148. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L 2008 Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327-1333
149. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A 2006 Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372
150. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A 2005 Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761
151. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G 2007 Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175-1186
152. Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L 2008 Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 5:417-424
153. Parekkadan B, Tilles AW, Yarmush ML 2008 Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26:1913-1919
154. Zanone MM, Favaro E, Miceli I, Grassi G, Camussi E, Caorsi C, Amoroso A, Giovarelli M, Perin PC, Camussi G 2010 Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes. J Clin Endocrinol Metab 95:3788-3797
155. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ 2006 Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103:17438-17443
156. Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C 2009 Mesenchymal stem cells protectNODmice from diabetes by inducing regulatory T cells. Diabetologia 52:1391-1399
157. Uccelli A, Moretta L, Pistoia V 2008 Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736
158. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F 2006 Role for interferon-g in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398
159. Chandra V, G S, Phadnis S, Nair PD, Bhonde RR 2009 Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 27:1941-1953
160. Hisanaga E, Park KY, Yamada S, Hashimoto H, Takeuchi T, Mori M, Seno M, Umezawa K, Takei I, Kojima I 2008 A simple method to induce differentiation of murine bone marrow mesenchymal cells to insulin-producing cells using conophylline and betacellulin-D4. Endocr J 55:535-543
161. Chen LB, Jiang XB, Yang L 2004 Differentiation of rat marrow mesenchymal stem cells into pancreatic islet β-cells. World J Gastroenterol 10:3016-3020
162. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, Zerbini G, Allavena P, Bonifacio E, Piemonti L 2005 Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427
163. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I 2004 A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645
164. Von Lüttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, Seliger C, Djafarzadeh R, Huss R, Nelson PJ 2005 Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 14:329-336
165. Le Blanc K, Ringdén O 2005 Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321-334
166. Gafni Y, Turgeman G, Liebergal M, Pelled G, Gazit Z, Gazit D 2004 Stem cells as vehicles for orthopedic gene therapy. Gene Ther 11:417-426
167. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK 2007 Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362-1369
168. Huang S, Law P, Young D, Ho AD 1998 Candidate he-matopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp Hematol 26:1162-1171
169. Herzog EL, Chai L, Krause DS 2003 Plasticity of marrowderived stem cells. Blood 102:3483-3493
170. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Halasa M, Król M, Kazmierski M, Buszman P, Ochala A, Ratajczak J, Machaliñski B, Ratajczak MZ 2009 Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 53:1-9
171. Sigvardsson M 2009 New light on the biology and developmental potential of haematopoietic stem cells and progenitor cells. J Intern Med 266:311-324
172. Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, Gratwohl A 1997 Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 349:254
173. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-FreitasMC, Simões BP, Foss MC, Squiers E, Burt RK 2007 Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297:1568-1576
174. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kö tter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R 2010 Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95:284-292
175. Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, Uno K, Gao J, Kaneko K, Ishihara H, Sasano H, Nakauchi H, Oka Y, Katagiri H 2007 Bone marrow (BM) transplantation promotes -cell regeneration after acute injury through BM cell mobilization. Endocrinology 148:2006-2015
176. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B 1992 Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89: 2804-2808
177. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM 1989 Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563-1570
178. Bryder D, Rossi DJ, Weissman IL 2006 Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 169:338-346
179. Nielsen JS, McNagny KM 2009 CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16:487-496
180. Kang EM, Zickler PP, Burns S, Langemeijer SM, Brenner S, Phang OA, Patterson N, Harlan D, Tisdale JF 2005 Hematopoietic stem cell transplantation prevents diabetes inNODmice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol 33: 699-705
181. Hai-Jiang W, Xin-Na D, Hui-Jun D 2008 Expansion of hematopoietic stem/progenitor cells. Am J Hematol 83: 922-926
182. Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V,Hö cker P, Fischer G, Dieckmann K, Handgretinger R, Klingebiel T, Gadner H 1999 Transplantation of highly purified peripheral blood CD34 cells from HLA-mismatched parental donors in14children: evaluation of early monitoring of engraftment. Leukemia 13:2070-2078
183. Petzer AL, Zandstra PW, Piret JM, Eaves CJ 1996 Differential cytokine effects on primitive (CD34 CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551-2558
184. Kwok YK, Tang MH, Law HK, Ngai CS, Lau YL, Lau ET 2007 Maternal plasma or human serum albumin in wash buffer enhances enrichment and ex vivo expansion of human umbilical cord blood CD34 cells. Br J Haematol 137:468-474
185. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ 2007 Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39:11-23
186. Koestenbauer S, Zisch A, Dohr G, Zech NH 2009 Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant 18:1059-1068
187. Fiorina P, Jurewicz M, Vergani A, Petrelli A, Carvello M, D'Addio F, Godwin JG, Law K, Wu E, Tian Z, Thoma G, Kovarik J, La Rosa S, Capella C, Rodig S, Zerwes HG, SayeghMH, Abdi R 2011 Targeting theCXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol 186:121-131
188. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF 2009 Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 361:2309-2317
189. Steptoe RJ, Ritchie JM, Jones LK, Harrison LC 2005 Autoimmune diabetes is suppressed by transfer of proinsulinencoding Gr-1 myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes 54:434-442
190. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y 1995 Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1:1268-1273
191. Gur H, Krauthgamer R, Berrebi A, Klein T, Nagler A, Tabilio A, Martelli MF, Reisner Y 2002 Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood 99:4174-4181
192. Gur H, Krauthgamer R, Bachar-Lustig E, Katchman H, Arbel-Goren R, Berrebi A, Klein T, Nagler A, Tabilio A, Martelli MF, Reisner Y 2005 Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-a. Blood 105:2585-2593
193. Kared H, Leforban B, Montandon R, Renand A, Layseca Espinosa E, Chatenoud L, Rosenstein Y, Schneider E, Dy M, Zavala F 2008 Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors. Blood 112:2575-2578
194. Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A, Martelli M, Reisner Y 1998 Tolerance induction by "megadose" hematopoietic transplants: donortype human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 65:1386-1393
195. Lord BI, Gurney H, Chang J, Thatcher N, Crowther D, Dexter TM 1992 Haemopoietic cell kinetics in humans treated with rGM-CSF. Int J Cancer 50:26-31
196. Imamura M 2002 Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantation. Int J Hematol 76(Suppl 1):191-194
197. Watt SM, Forde SP 2008 The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders? Vox Sang 94:18-32
198. Broxmeyer HE, Hangoc G, Cooper S, Campbell T, Ito S, Mantel C 2007 AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Ann NY Acad Sci 1106:1-19
199. Tchernychev B, Ren Y, Sachdev P, Janz JM, Haggis L, O'Shea A, McBride E, Looby R, Deng Q, McMurry T, Kazmi MA, Sakmar TP, Hunt 3rd S, Carlson KE 2010 Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc Natl Acad Sci USA 107:22255-22259
200. Butler AE, Huang A, Rao PN, Bhushan A, Hogan WJ, Rizza RA, Butler PC 2007 Hematopoietic stem cells derived from adult donors are not a source of pancreatic b-cells in adult nondiabetic humans. Diabetes 56:1810-1816
201. Ianus A, Holz GG, Theise ND, Hussain MA 2003 In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111:843-850
202. WangX, Ge S, Gonzalez I,McNamaraG, Rountree CB, Xi KK, Huang G, Bhushan A, Crooks GM 2006 Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells 24:307-314
203. Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, Boespflug ND, Bingley PJ, Gale EA 2007 Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet b cell microchimerism. Proc Natl Acad Sci USA 104:1637-1642
204. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC 2009 C-Peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301:1573-1579
205. Snarski E, Milczarczyk A, Torosian T, Paluszewska M, Urbanowska E, Król M, Boguradzki P, Jedynasty K, Franek E, Wiktor-Jedrzejczak W 2011 Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. Bone Marrow Transplant 46:562-566
206. Hess D, Li L, MartinM,Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M 2003 Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21: 763-770
207. Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang LJ 2004 In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53:1721-1732
208. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA 2004 Recruitment of bone marrow-derived endothelial cells to sites of pancreatic b-cell injury. Diabetes 53:91-98
209. Ross LF, Philipson LH 2007 Ethics of hematopoietic stem cell transplantation in type 1 diabetes mellitus.JAMA 298: 285; author reply 285-286
210. Kim EY, Jeon K, Park HY, Han YJ, Yang BC, Park SB, ChungHM, Park SP 2010 Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts. Cell Reprogram 12:627-639
211. Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Pucéat M 2009 Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol 186:665-673
212. MarchettoMC, YeoGW,Kainohana O, Marsala M, Gage FH, Muotri AR 2009 Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4:e7076
213. Takahashi K, Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
214. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872
215. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920
216. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA 2008 Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275
217. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K 2008 Induced pluripotent stem cells generated without viral integration. Science 322:945-949
218. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA 2009 Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801
219. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S 2008 Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953
220. Lin SL, Chang DC, Lin CH, Ying SY, Leu D,Wu DT 2011 Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 39:1054-1065
221. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämä läinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A 2009 piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-770
222. Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW 2010 Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 6:270-281
223. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ 2010 Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630
224. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Biliæ J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisú a Belmonte JC 2008 Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284
225. Tolar J, Xia L, Riddle MJ, Lees CJ, Eide CR, McElmurry RT, Titeux M, Osborn MJ, Lund TC, Hovnanian A, Wagner JE, Blazar BR 2011 Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131:848-856
226. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, Yamaguchi T, Otsu M, Nishimura K, Nakanishi M, Sawaguchi A, Nagai R, Takahashi K, Yamanaka S, Nakauchi H, Eto K 2010 Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207:2817-2830
227. Pessach IM, Ordovas-Montanes J, Zhang SY, Casanova JL, Giliani S, Gennery AR, Al-Herz W, Manos PD, Schlaeger TM, Park IH, Rucci F, Agarwal S, Mostoslavsky G, Daley GQ, Notarangelo LD 2011 Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol 127:1400-1407.e4
228. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ 2008 Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146
229. Ruiz S, Brennand K, Panopoulos AD, Herrerías A, Gage FH, Izpisua-Belmonte JC 2010 High-efficient generation of induced pluripotent stem cells from human astrocytes. PLoS One 5:e15526
230. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, Okada Y, Seimiya H, Fusaki N, Hasegawa M, Fukuda K 2010 Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14
231. Brown ME, Rondon E, Rajesh D, Mack A, Lewis R, Feng X, Zitur LJ, Learish RD, Nuwaysir EF 2010 Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 5:e11373
232. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L 2009 Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114:5473-5480
233. Medvedev SP, Grigor'eva EV, Shevchenko AI, Malakhova AA, Dementyeva EV, Shilov AA, Pokushalov EA, Zaidman AM, Aleksandrova MA, Plotnikov EY, Sukhikh GT, Zakian SM 2011 Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev 20: 1099-1112
234. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC 2011 Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 6:78-88
235. Shao L, FengW,Sun Y, Bai H, Liu J, Currie C,KimJ,Gama R, Wang Z, Qian Z, Liaw L, Wu WS 2009 Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19: 296-306
236. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodríguez-Piza' I, Vassena R, Raya A, Boué S, Barrero MJ, Corbella BA, Torrabadella M, Veiga A, Izpisua Belmonte JC 2009 Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5:353-357
237. Suá rez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, Ortega F, Otero J, Cibelli JB, Moore H, Fraga MF, López-Larrea C 2010 Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 5:e10192
238. Zhao T, Zhang ZN, Rong Z, Xu Y 2011 Immunogenicity of induced pluripotent stem cells. Nature 474:212-215
239. Senju S, Haruta M, Matsunaga Y, Fukushima S, Ikeda T, Takahashi K, Okita K, Yamanaka S, Nishimura Y 2009 Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27:1021-1031
240. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA 2009 Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106:15768-15773
241. Maehr R 2011 iPS cells in type 1 diabetes research and treatment. Clin Pharmacol Ther 89:750-753
242. de Souza N 2010 iPS cell aberrations. Nat Methods 7:948-949
243. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N 2010 Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7:521-531
244. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, Yu J, Hebrok M, Hochedlinger K, Costello JF, Song JS, Ramalho-SantosM 2011 Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13:541-549
245. Tokumoto Y, Ogawa S, Nagamune T, Miyake J 2010 Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro. J Biosci Bioeng 109:622-628
246. Hu Q, Friedrich AM, Johnson LV, Clegg DO 2010 Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28:1981-1991
247. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R 2010 Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712
248. Taylor-Fishwick DA, Pittenger GL 2010 Harnessing the pancreatic stem cell. Endocrinol Metab Clin North Am 39:763-776
249. Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sa-chinidis A 2010 Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr Med Chem 17:759-766
250. Maherali N, Hochedlinger K 2008 Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3:595-605
251. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K 2008 Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221
252. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, VenturiniM, Socci C, Davalli A, Orsenigo E, Monti L, Falqui L, Uccella S, La Rosa S, Usellini L, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A 2003 Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26:1129-1136
253. Chan KM, Raikwar SP, Zavazava N 2007 Strategies for differentiating embryonic stem cells (ESC) into insulinproducing cells and development of non-invasive imaging techniques using bioluminescence. Immunol Res 39:261-270
254. Okita K, Hong H, Takahashi K, Yamanaka S 2010 Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 5:418-428
255. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R,GruhI, Meyer J, Wagner S, Maier LS, Han DW, Glage S, Miller K, Fischer P, Schö ler HR, Martin U 2009 Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5:434-441
256. Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD 2009 How I treat ADA deficiency. Blood 114:3524-3532
257. Couri CE, Voltarelli JC 2011 Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes. Curr Stem Cell Res Ther 6:10-15
258. Wu XH, Liu CP, Xu KF, Mao XD, Zhu J, Jiang JJ, Cui D, Zhang M, Xu Y, Liu C 2007 Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol 13:3342-3349
259. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE 2004 Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 84:607-617
260. Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D, Favrot M, Benhamou PY 2005 Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 23: 594-603
261. Li Y, Zhang R, Qiao H, Zhang H, Wang Y, Yuan H, Liu Q, Liu D, Chen L, Pei X 2007 Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol 211:36-44
262. Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun J, Tang KX, Wang B, Song J, Li H, Wang KX 2007 Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) 120:771-776
263. Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S 2007 Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25:2837-2844
264. Xie QP, Huang H, Xu B, Dong X, Gao SL, Zhang B, Wu YL 2009 Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation 77:483-491